摘要
目的研究盐酸利托君片+硫酸镁运用于早产产妇中的价值。方法选择新密市妇幼保健院2020年6月至2021年12月接收的82例早产产妇,按随机排列法划分成两组,各41例,研究组选择盐酸利托君片+硫酸镁,对照组使用硫酸镁。评价两组用药后的治疗有效率,统计两组宫缩抑制、治疗时长、孕龄延长时间、产后出血量、剖宫产率、阴道分娩率、新生儿并发症(败血症、肺炎、呼吸窘迫)、产妇并发症(恶心呕吐、心悸胸闷、震颤麻木),新生儿出生后1 min进行Apgar评分、新生儿的出生体重,比较两组用药结果。结果研究组治疗有效率(90.24%)高出对照组(68.29%),差异有统计学意义(P<0.05)。研究组宫缩抑制、治疗时长、产后出血量均低于对照组,但孕龄延长时间长于对照组,差异有统计学意义(P<0.05)。研究组剖宫产率及阴道分娩率与对照组比较,差异无统计学意义(P>0.05)。研究组新生儿并发症发生率(7.32%)低于对照组(26.83%),但产妇并发症发生率高出对照组,差异有统计学意义(P<0.05)。研究组新生儿出生后1 min Apgar评分、出生体重均高出对照组,差异有统计学意义(P<0.05)。结论虽然产妇使用盐酸利托君片+硫酸镁的效果更为显著,可缩短宫缩抑制时间,同时减少产后出血量,产妇的并发症较多,围生儿结局较为理想,可为临床治疗早产产妇提供借鉴。
Objective To study the clinical value of ritodrine hydrochloride tablets and magnesium sulfate in premature delivery women.Methods A total of 82 premature delivery women registered in our hospital from June 2020 to December 2021were selected.According to random permutation method,women were assigned to research group(N=41,ritodrine hydrochloride tablets and magnesium sulfate)and control group(N=41,magnesium sulfate).Medication outcomes were appraised through the total effective rate,uterine contraction inhibition and treatment time,gestational age extension time,postpartum bleeding volume,cesarean section and vaginal delivery ratios,neonatal complications like septicemia,pneumonia and respiratory distress,maternal complications like nausea and vomiting,palpitation and chest distress,shaking palsy,neonatal Apgar points after 1min of delivery as well as birth weight of the newborn baby.Results The total effective rate in the research group(90.24%)was higher than control group(68.29%),the difference was statistically significant(P<0.05);The uterine contraction inhibition,treatment duration and postpartum hemorrhage in the study group were lower than those in the control group,but the pregnancy age was longer than that in the control group,the differences were statistically significant(P<0.05);Cesarean section and vaginal delivery ratios between research group and control group were not significantly different(P>0.05);The neonatal complication rate in the research group(7.32%)was lower than control group(26.83%),but the maternal complication rate was higher than control group,the differences were statistically significant(P<0.05);The neonatal Apgar points after 1 min of delivery and birth weight in the research group were higher than control group,the differences were statistically significant(P<0.05).Conclusion Although the maternal use of rittojun hydrochloride tablets combined with magnesium sulfate is more effective,which can shorten the inhibition time of contractions and reduce the amount of postpartum bleeding,there are more maternal complications,but has ideal perinatal outcome,which can provide reference for the clinical treatment of premature women.
作者
张晓静
牛淑娟
李玲玲
ZHANG Xiaojing;NIU Shujuan;LI Lingling(Department of Obstetrics,Xinmi Maternal and Child Health Hospital,Zhengzhou Henan 452370,China)
出处
《临床研究》
2022年第11期57-59,共3页
Clinical Research
关键词
早产产妇
盐酸利托君片
硫酸镁
分娩结局
premature delivery women
ritodrine hydrochloride tablets
magnesium sulfate
delivery outcomes
